Alzamend Neuro Gets FDA Approval for Trial of Depression Treatment

By Dean Seal


Alzamend Neuro has gotten the go-ahead from federal regulators to launch a clinical study of its treatment for major depressive disorder.

The biopharmaceutical company said...

Related Keywords

Stephan Jackman ,Drug Administration ,Dean Seal ,Executive Stephan Jackman ,Dow Jones ,Markets ,